| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/2003 | US6514492 Methacrylic acid polymer crosslinked with divinylbenzene as the carrier; orbifloxacin; |
| 02/04/2003 | US6514491 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 02/04/2003 | US6514490 Compositions containing an antifungal and a cationic agent |
| 02/04/2003 | US6514489 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 02/04/2003 | US6514486 Inhibits tyrosinase or the synthesis of melanin; N'-(4-hydroxyphenyl)-N,N-dimethylformamidine |
| 02/04/2003 | US6514484 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier |
| 02/04/2003 | CA2421787A1 Aqueous pharmaceutical compositions |
| 02/04/2003 | CA2362539C Fluorocarbon aerosol medicaments |
| 02/04/2003 | CA2290766C Method of treating nitrate-induced tolerance |
| 02/04/2003 | CA2272927C Dimesylate salts of neuropeptide y ligands |
| 02/04/2003 | CA2271566C Substituted phenyl pyrimidines useful in the treatment of cns disorders |
| 02/04/2003 | CA2271478C Tissue specific expression of retinoblastoma protein |
| 02/04/2003 | CA2268967C Pharmaceutical preparations comprised of salts of hyaluronic acid with local anaesthetics |
| 02/04/2003 | CA2253490C Use of il-12 and ifn-.alpha. for the treatment of infectious diseases |
| 02/04/2003 | CA2178479C Chroman derivatives |
| 02/04/2003 | CA2169019C Improvements in platinum complexes |
| 02/04/2003 | CA2112818C Mono and bis alkylamino-anthracyclines |
| 02/04/2003 | CA2057528C Low estrogen oral contraceptives |
| 02/03/2003 | WO2002016312A2 Novel compounds inhibiting factor xa activity |
| 02/03/2003 | CA2418283A1 Novel compounds inhibiting factor xa activity |
| 02/03/2003 | CA2393357A1 Concentrated water-dispersible vitamin compositions |
| 02/03/2003 | CA2393189A1 Non-combustible water-dispersible vitamin compositions |
| 02/03/2003 | CA2391627A1 Ribosome structure and protein synthesis inhibitors |
| 02/01/2003 | CA2395006A1 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production |
| 01/31/2003 | WO2002007761A1 Inhibiting hepatitis c virus processing and replication |
| 01/31/2003 | CA2416603A1 Inhibiting hepatitis c virus processing and replication |
| 01/31/2003 | CA2354486A1 C7 ester substituted taxanes |
| 01/31/2003 | CA2354478A1 C10 carbonate substituted taxanes |
| 01/31/2003 | CA2354471A1 C10 ester substituted taxanes |
| 01/30/2003 | WO2003008644A1 Method of screening abc protein promoter/inhibitor |
| 01/30/2003 | WO2003008640A2 Asthma-associated gene |
| 01/30/2003 | WO2003008595A2 Novel oligoribonucleotide derivatives for the targeted inhibition of gene expression |
| 01/30/2003 | WO2003008576A2 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression |
| 01/30/2003 | WO2003008574A1 Mutations in ion channels |
| 01/30/2003 | WO2003008573A2 Silencing of gene expression by sirna |
| 01/30/2003 | WO2003008495A1 Pullulan-containing powder, process for producing the same and use thereof |
| 01/30/2003 | WO2003008480A1 Positively charged amphiphilic block copolymer as drug carrier and complex thereof with negatively charged drug |
| 01/30/2003 | WO2003008457A2 Polysaccharidic esters of retinoic acid |
| 01/30/2003 | WO2003008454A2 Glycoprotein vi fusion proteins |
| 01/30/2003 | WO2003008448A2 Novel human proton-gated channels |
| 01/30/2003 | WO2003008430A2 Porphyrin derivatives for photodynamic therapy |
| 01/30/2003 | WO2003008429A2 Solvent-free anthracycline derivatives |
| 01/30/2003 | WO2003008425A1 Novel bisphosphonate derivatives, their preparation methods and uses |
| 01/30/2003 | WO2003008423A1 New antitumoral derivatives of et-743 |
| 01/30/2003 | WO2003008422A1 Chemical compounds |
| 01/30/2003 | WO2003008420A1 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]naphthalenyl derivatives with antipsychotic activity |
| 01/30/2003 | WO2003008419A1 2-(AMINOMETHYL)-TETRAHYDRO-9-OXA-1,3-DIAZA-CYCLOPENTA[a]NAPHTHALENYL DERIVATIVES WITH ANTIPSYCHOTIC ACTIVITY |
| 01/30/2003 | WO2003008418A1 Imidazo-triazine derivatives as ligands for gaba receptors |
| 01/30/2003 | WO2003008414A1 Chemical compounds |
| 01/30/2003 | WO2003008413A1 Imidazopyridinones as p38 map kinase inhibitors |
| 01/30/2003 | WO2003008412A2 Hetero-bicyclic crf antagonists |
| 01/30/2003 | WO2003008411A1 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 01/30/2003 | WO2003008410A2 Polypyrroles as agents for treating cancer, treating viral diseases and causing immunosuppression |
| 01/30/2003 | WO2003008409A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 01/30/2003 | WO2003008407A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 01/30/2003 | WO2003008399A1 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors |
| 01/30/2003 | WO2003008398A1 Aryl substituted thiazolidinones and the use thereof |
| 01/30/2003 | WO2003008396A1 Optically active oxazine derivative |
| 01/30/2003 | WO2003008395A1 Substituted isoxazoles and the use thereof as antibiotics |
| 01/30/2003 | WO2003008394A1 Novel chelating agents and conjugates thereof, their synthesis and use as diagnostic and therapeutic agents |
| 01/30/2003 | WO2003008392A1 4-(benzylidene-amino)-3-(methylsulfanyl)-4h-(1, 2, 4) triazin-5-one derivatives having a pde-iv inhibiting and tnf-antagonistic effect for the treatment of cardiac diseases and allergies |
| 01/30/2003 | WO2003008387A1 Compounds useful for treatment or prevention of disease mediated by alpha-2b-adrenoceptor |
| 01/30/2003 | WO2003008384A1 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 01/30/2003 | WO2003008380A1 Carboxylic acid derivatives |
| 01/30/2003 | WO2003008377A1 Prostaglandin analogues_as ep4 receptor agonists |
| 01/30/2003 | WO2003008374A1 Inhibitors of the ice/ced-3 family of cysteine proteases |
| 01/30/2003 | WO2003008371A1 Substituted 4-aminocyclohexanol derivatives |
| 01/30/2003 | WO2003008370A1 Substituted 4-aminocyclohexanols |
| 01/30/2003 | WO2003008368A1 Process and intermediates to prepare latanoprost |
| 01/30/2003 | WO2003008365A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents |
| 01/30/2003 | WO2003008038A1 Electro-medical device for use with biologics |
| 01/30/2003 | WO2003008016A2 Mating insertion instruments for spinal implants and methods of use |
| 01/30/2003 | WO2003007995A2 Pharmaceutical preparations containing ion exchange resins charged with fluoroquinolone |
| 01/30/2003 | WO2003007994A2 Thyroid therapeutic agents containing partial glycerides and dextrin |
| 01/30/2003 | WO2003007993A1 Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor |
| 01/30/2003 | WO2003007992A1 Remedies for brain ischemic diseases |
| 01/30/2003 | WO2003007991A1 Pancreatic juice secretion regulators comprising lpa receptor controller |
| 01/30/2003 | WO2003007990A1 Myosin agonist |
| 01/30/2003 | WO2003007988A1 Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 01/30/2003 | WO2003007984A1 Uv cross-linkable melt adhesives containing stabilizers |
| 01/30/2003 | WO2003007979A1 An anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration |
| 01/30/2003 | WO2003007978A1 Alpha-fetoprotein peptides and uses thereof |
| 01/30/2003 | WO2003007975A1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 01/30/2003 | WO2003007973A1 Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia |
| 01/30/2003 | WO2003007970A2 Use of magnesium for preventing in-stent thrombosis and complications after arterial angioplasty with stent placement |
| 01/30/2003 | WO2003007969A1 Bio-compatible molecules for improving vision |
| 01/30/2003 | WO2003007968A1 A cardiotonic composition |
| 01/30/2003 | WO2003007967A1 Medical preparation for parenteral injection |
| 01/30/2003 | WO2003007966A1 Active substance combination for medicamentous therapy of nicotine dependency |
| 01/30/2003 | WO2003007964A1 Remedial or preventive agent for cardiopathy or aneurysm containing chymase inhibitory compound |
| 01/30/2003 | WO2003007962A1 A combination therapy for the treatment of heart failure |
| 01/30/2003 | WO2003007961A1 Methods for treating neoplastic, angiogenic, fibroplastic, and/or immunosuppresive ocular irregularities via administration of methotrexate based medicaments, and ocular iontophoretic devices for delivering methotrexate based medicaments |
| 01/30/2003 | WO2003007960A1 Method for protecting human skin against infections and a dermatic for carrying out said method |
| 01/30/2003 | WO2003007959A1 Quinoxaline derivatives which have parp inhibitory action |
| 01/30/2003 | WO2003007958A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 01/30/2003 | WO2003007957A1 Method and composition for treatment of cancer |
| 01/30/2003 | WO2003007956A1 Treatment for attention-deficit hyperactivity disorder |
| 01/30/2003 | WO2003007955A2 Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer |
| 01/30/2003 | WO2003007954A2 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 01/30/2003 | WO2003007953A1 Methods and compositions for modulating t-type calcium channels |